Efficacy and Safety of GSK1358820 (Botulinum Toxin Type A) in Patients With Strabismus
Clinical trial NCT01584843 · COMPLETED
Trial details
- NCT number
- NCT01584843
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-05-01
- Primary completion
- 2013-07-01
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.